Advances in Molecular Diagnosis of Neurofibromatosis Type 1

被引:26
|
作者
Shofty, Ben [1 ,3 ]
Constantini, Shlomi [1 ,2 ,3 ]
Ben-Shachar, Shay [3 ,4 ]
机构
[1] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Div Neurosurg, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Gilbert Israeli Neurofibromatosis Ctr, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Tel Aviv Med Ctr, Sackler Fac Med, Genet Inst, IL-69978 Tel Aviv, Israel
关键词
PREIMPLANTATION GENETIC DIAGNOSIS; NF1; GENE; MUTATIONS; PHENOTYPE; GENOTYPE; SPECTRUM; INACTIVATION; EXPRESSION; MOSAICISM; STENOSIS;
D O I
10.1016/j.spen.2015.10.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis 1 (NF1) is a common neurocutaneous and tumor predisposing genetic disorder with an autosomal dominant mode of inheritance. NF1 is solely caused by mutations in the NF1 gene, and disease-causing mutations can be found in more than 95% of individuals with a clinical diagnosis. Although NF1 has a distinctive clinical phenotype, it has a highly variable expression, even among individuals from the same family. Identifying the specific mutation does not usually assist in determining disease course and severity, and relatively few genotype-phenotype correlations have thus far been found. This review discusses the basic clinical aspects of NF1 and the current explanations for the high phenotypic variability, and provides the recently detected genotype-phenotype correlations. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:234 / 239
页数:6
相关论文
共 50 条
  • [21] Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1
    Jiang, Chunhui
    Mckay, Renee M.
    Lee, Sang Y.
    Romo, Carlos G.
    Blakeley, Jaishri O.
    Haniffa, Muzlifah
    Serra, Eduard
    Steensma, Matthew R.
    Largaespada, David
    Le, Lu Q.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (08) : 1369 - 1377
  • [22] Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
    Ottenhoff, Myrthe J.
    Rietman, Andre B.
    Mous, Sabine E.
    Plasschaert, Ellen
    Gawehns, Daniela
    Brems, Hilde
    Oostenbrink, Rianne
    van Minkelen, Rick
    Nellist, Mark
    Schorry, Elizabeth
    Legius, Eric
    Moll, Henriette A.
    Elgersma, Ype
    de Wit, Marie-Claire Y.
    de Nijs, Pieter F. A.
    Legerstee, Jeroen S.
    Dieleman, Gwendolyn C.
    ten Hoopen, Leontine W.
    GENETICS IN MEDICINE, 2020, 22 (05) : 889 - 897
  • [23] Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1
    Pacot, Laurence
    Sabbagh, Audrey
    Sohier, Pierre
    Hadjadj, Djihad
    Ye, Manuela
    Boland-Auge, Anne
    Bacq-Daian, Delphine
    Laurendeau, Ingrid
    Briand-Suleau, Audrey
    Deleuze, Jean-Francois
    Margueron, Raphael
    Vidaud, Michel
    Ferkal, Salah
    Parfait, Beatrice
    Vidaud, Dominique
    Pasmant, Eric
    Wolkenstein, Pierre
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (02) : 226 - 243
  • [24] Deletion of the whole NF1 gene in a three-generation family with neurofibromatosis type 1
    Du, Qin
    Chen, Hongxi
    Zhou, Hongyu
    NEUROLOGICAL SCIENCES, 2022, 43 (02) : 1295 - 1301
  • [25] NF1 single and multi-exons copy number variations in neurofibromatosis type 1
    Imbard, Apolline
    Pasmant, Eric
    Sabbagh, Audrey
    Luscan, Armelle
    Soares, Magali
    Goussard, Philippe
    Blanche, Helene
    Laurendeau, Ingrid
    Ferkal, Salah
    Vidaud, Michel
    Pinson, Stephane
    Bellanne-Chantelot, Christine
    Vidaud, Dominique
    Wolkenstein, Pierre
    Parfait, Beatrice
    JOURNAL OF HUMAN GENETICS, 2015, 60 (04) : 221 - 224
  • [26] Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis
    Melean, German
    Marina Hernandez, Alba
    Carmen Valero, Maria
    Hernandez-Imaz, Elisabete
    Martin, Yolanda
    Hernandez-Chico, Concepcion
    BMC CANCER, 2010, 10
  • [27] Advances in the diagnosis and management of type 1 von Willebrand disease
    Castaman, Giancarlo
    Rodeghiero, Francesco
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 95 - 106
  • [28] Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
    Pimentel, Mariana Flores
    Heath, Anna
    Wan, Michael J.
    Hussein, Rowaida
    Leahy, Kate E.
    MacDonald, Heather
    Tavares, Erika
    VandenHoven, Cynthia
    MacNeill, Katelyn
    Kannu, Peter
    Parkin, Patricia C.
    Heon, Elise
    Reginald, Arun
    Vincent, Ajoy
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2022, 11 (02):
  • [29] Clinical and Molecular Profile of Neurofibromatosis Type 1 Patients Using Revised Diagnostic Criteria - A Retrospective Cohort Study
    Rekha, A.
    Sanoop, A. V. Muhammed
    Das, Sweta
    Chapla, Aaron
    Srinageshwari, Bhairavi
    Barney, Anitha
    Arunachalam, Gautham
    Mohan, Sony
    Danda, Sumita
    NEUROLOGY INDIA, 2024, 72 (06) : 1174 - 1178
  • [30] NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
    Sabbagh, Audrey
    Pasmant, Eric
    Imbard, Apolline
    Luscan, Armelle
    Soares, Magali
    Blanche, Helene
    Laurendeau, Ingrid
    Ferkal, Salah
    Vidaud, Michel
    Pinson, Stephane
    Bellanne-Chantelot, Christine
    Vidaud, Dominique
    Parfait, Beatrice
    Wolkenstein, Pierre
    HUMAN MUTATION, 2013, 34 (11) : 1510 - 1518